Literature DB >> 12699802

Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia.

Eduard Gratacós1, Elena Casals, Olga Gómez, Elisa Llurba, Imma Mercader, Vicenç Cararach, Lluís Cabero.   

Abstract

OBJECTIVES: To evaluate the susceptibility to oxidation of low density lipoprotein (LDL) in women with a history of pre-eclampsia.
DESIGN: A case-control study.
SETTING: The departments of obstetrics and gynaecology at two university teaching hospitals. POPULATION: Women delivering one to three years before enrollment, 35 who were diagnosed with severe pre-eclampsia and 35 controls matched for age, body mass index (BMI), smoking and parity.
METHODS: Plasma samples were analysed for total cholesterol, high density lipoprotein (HDL) cholesterol, LDL cholesterol, triglycerides and lipoprotein A. The in vitro susceptibility to oxidation of LDL was measured and expressed in minutes (lag time). Results are expressed as mean and standard deviation. MAIN OUTCOME MEASURES: Serum lipid profile and in vitro susceptibility to oxidation of LDL.
RESULTS: Mean LDL cholesterol (116 [37] vs 98 [20] mg/dL, P < 0.05) and trygliceride (112 [56] vs 78 [38] mg/dL, P < 0.05) levels were significantly higher in the groups of women who had pre-eclampsia compared with controls. The rest of the measured lipid parameters were similar between the two study groups. The susceptibility to oxidation of LDL was also significantly higher in the pre-eclampsia group (lag time: 37.9 [8.4] vs 44.8 [9.1] minutes, P < 0.01).
CONCLUSION: Women with a history of pre-eclampsia have significant differences in lipid parameters and an increased susceptibility to lipoprotein oxidation when compared with women who had a normal pregnancy one to three years after delivery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699802

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  11 in total

1.  Study of serum lipid profile in pregnancy induced hypertension.

Authors:  Jayanta De; Ananda Mukhopadhyay; Pradip Kumar Saha
Journal:  Indian J Clin Biochem       Date:  2006-09

Review 2.  Statins in Pregnancy: Can We Justify Early Treatment of Reproductive Aged Women?

Authors:  Amelie Pham; Aleksandra Polic; Lynsa Nguyen; Jennifer L Thompson
Journal:  Curr Atheroscler Rep       Date:  2022-06-14       Impact factor: 5.967

Review 3.  Cholesterol in pregnancy: a review of knowns and unknowns.

Authors:  Änne Bartels; Keelin O'Donoghue
Journal:  Obstet Med       Date:  2011-07-28

4.  Association of Lipid Profile and Uric Acid with Pre-eclampsia of Third Trimester in Nullipara Women.

Authors:  Vibhuti Agarwal; Bharat Kumar Gupta; Abhishek Vishnu; Jas Kiran
Journal:  J Clin Diagn Res       Date:  2014-07-20

5.  The relationship between metabolic syndrome criteria and preeclampsia in primigravid women.

Authors:  Maryam Kianpour; Shahla Norozi; Parvin Bahadoran; Leila Azadbakht
Journal:  Iran J Nurs Midwifery Res       Date:  2015 Mar-Apr

6.  Lipid Profile and High Maternal Body Mass Index is Associated with Preeclampsia: A Case-Control Study of the Cape Coast Metropolis.

Authors:  Rkd Ephraim; Pa Doe; S Amoah; Eo Antoh
Journal:  Ann Med Health Sci Res       Date:  2014-09

7.  Morphometric evaluation of preeclamptic placenta using light microscopic images.

Authors:  Rashmi Mukherjee
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

8.  Maternal Serum Lipids in Women with Pre-eclampsia.

Authors:  Ia Siddiqui
Journal:  Ann Med Health Sci Res       Date:  2014-07

9.  Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China.

Authors:  Wen-Yuan Jin; Sheng-Liang Lin; Ruo-Lin Hou; Xiao-Yang Chen; Ting Han; Yan Jin; Li Tang; Zhi-Wei Zhu; Zheng-Yan Zhao
Journal:  BMC Pregnancy Childbirth       Date:  2016-03-21       Impact factor: 3.007

Review 10.  Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when.

Authors:  T Katrien J Groenhof; Bas B van Rijn; Arie Franx; Jeanine E Roeters van Lennep; Michiel L Bots; A Titia Lely
Journal:  Eur J Prev Cardiol       Date:  2017-09-12       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.